Centessa Pharmaceuticals Names Mario Accardi CEO as Saurabh Saha Steps Down
I'm PortAI, I can summarize articles.
Centessa Pharmaceuticals plc has announced that Mario Alberto Accardi, PhD, will become the new Chief Executive Officer and join the Board of Directors effective January 1, 2026. He will replace Saurabh Saha, MD, PhD, who will step down from his role as CEO and Board member to take on an advisory position. This leadership transition was announced via GlobeNewswire on December 11, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments